JP2001526035A - Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド - Google Patents

Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド

Info

Publication number
JP2001526035A
JP2001526035A JP2000524441A JP2000524441A JP2001526035A JP 2001526035 A JP2001526035 A JP 2001526035A JP 2000524441 A JP2000524441 A JP 2000524441A JP 2000524441 A JP2000524441 A JP 2000524441A JP 2001526035 A JP2001526035 A JP 2001526035A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
oligonucleotide primer
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000524441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001526035A5 (enExample
Inventor
ロス，ブルース，カーター
バー，イアン，ジョージ
パターソン，ミシェル，アン
エイギアス，キャサリーン，テレセ
ロセル，リンダ，ジョイ
マーゲッツ，メイ，ブリジッド
ホッキング，ダイアナ，マーガレット
ウェッブ，エリザベス，アン
Original Assignee
シーエスエル、リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP0839A external-priority patent/AUPP083997A0/en
Priority claimed from AUPP1182A external-priority patent/AUPP118297A0/en
Priority claimed from AUPP1546A external-priority patent/AUPP154698A0/en
Priority claimed from AUPP2264A external-priority patent/AUPP226498A0/en
Priority claimed from AUPP2911A external-priority patent/AUPP291198A0/en
Priority claimed from AUPP3128A external-priority patent/AUPP312898A0/en
Priority claimed from AUPP3338A external-priority patent/AUPP333898A0/en
Priority claimed from AUPP3654A external-priority patent/AUPP365498A0/en
Priority claimed from AUPP4917A external-priority patent/AUPP491798A0/en
Priority claimed from AUPP4963A external-priority patent/AUPP496398A0/en
Priority claimed from AUPP5028A external-priority patent/AUPP502898A0/en
Application filed by シーエスエル、リミテッド filed Critical シーエスエル、リミテッド
Publication of JP2001526035A publication Critical patent/JP2001526035A/ja
Publication of JP2001526035A5 publication Critical patent/JP2001526035A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2000524441A 1997-12-10 1998-12-10 Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド Pending JP2001526035A (ja)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
AU2264 1985-09-03
AU4963 1986-03-10
AU1182 1993-09-13
AUPP0839A AUPP083997A0 (en) 1997-12-10 1997-12-10 Porphyromonas gingivalis nucleotides
AUPP1182A AUPP118297A0 (en) 1997-12-31 1997-12-31 P. gingivalis sequences
AUPP1546A AUPP154698A0 (en) 1998-01-30 1998-01-30 P. gingivalis sequences
AUPP2264A AUPP226498A0 (en) 1998-03-10 1998-03-10 Porphyromonas gingivalis probes and polypeptides
AUPP2911A AUPP291198A0 (en) 1998-04-09 1998-04-09 P. gingivalis sequences
AUPP3128A AUPP312898A0 (en) 1998-04-23 1998-04-23 Porphyromonas gingivalis antigens and probes
AUPP3338A AUPP333898A0 (en) 1998-05-05 1998-05-05 P. gingivalis sequences
AUPP3654A AUPP365498A0 (en) 1998-05-22 1998-05-22 P. gingivalis sequences
AUPP4917A AUPP491798A0 (en) 1998-07-29 1998-07-29 P.gingivalis nucleotides and polypeptides
AUPP4963A AUPP496398A0 (en) 1998-07-30 1998-07-30 P.gingivalis polypeptides
AU3128 1998-08-04
AU3654 1998-08-04
AU4917 1998-08-04
AU1546 1998-08-04
AU0839 1998-08-04
AU5028 1998-08-04
AUPP5028A AUPP502898A0 (en) 1998-08-04 1998-08-04 P.gingivalis antigens
PCT/AU1998/001023 WO1999029870A1 (en) 1997-12-10 1998-12-10 Porphorymonas gingivalis polypeptides and nucleotides
AU2911 1999-09-17
AU3338 1999-11-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009029661A Division JP5349070B2 (ja) 1997-12-10 2009-02-12 Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド

Publications (2)

Publication Number Publication Date
JP2001526035A true JP2001526035A (ja) 2001-12-18
JP2001526035A5 JP2001526035A5 (enExample) 2006-01-05

Family

ID=27581380

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000524441A Pending JP2001526035A (ja) 1997-12-10 1998-12-10 Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド
JP2009029661A Expired - Fee Related JP5349070B2 (ja) 1997-12-10 2009-02-12 Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009029661A Expired - Fee Related JP5349070B2 (ja) 1997-12-10 2009-02-12 Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド

Country Status (10)

Country Link
EP (10) EP2283855A3 (enExample)
JP (2) JP2001526035A (enExample)
KR (1) KR100603552B1 (enExample)
AT (1) ATE534742T1 (enExample)
AU (1) AU1648799A (enExample)
CA (1) CA2313823A1 (enExample)
DK (2) DK1908772T3 (enExample)
ES (2) ES2419664T3 (enExample)
NZ (1) NZ504811A (enExample)
WO (1) WO1999029870A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007529195A (ja) * 2003-08-15 2007-10-25 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インク． 歯周病の診断，治療，およびモニタリングのためのＰｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ毒性ポリヌクレオチドの同定
JP2010532766A (ja) * 2007-07-12 2010-10-14 オーラル ヘルス オーストラリア ピーティーワイ リミテッド バイオフィルムに対する免疫学的治療
WO2012081306A1 (ja) * 2010-12-15 2012-06-21 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
JP2015178533A (ja) * 2009-08-02 2015-10-08 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ ポルフィロモナス・ジンジバリス（Ｐｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ）ポリペプチド
JP7891763B1 (ja) * 2025-03-11 2026-07-17 貴俊 村田 オリゴヌクレオチドセット及び口腔細菌検出用キット並びに口腔細菌の検出方法及び口腔病原細菌検出用オリゴヌクレオチドセットの製造方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4648700A (en) * 1999-04-21 2000-11-02 Daniel Nelson A polypeptide having amidolytic activity for a serpin
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AU2001252042B2 (en) * 2000-04-28 2005-12-01 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
JP2003192616A (ja) * 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
GB0411150D0 (en) * 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
CA2652957A1 (en) * 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
EP2638905B1 (en) * 2007-07-12 2019-01-16 Oral Health Australia Pty Ltd Biofilm treatment
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
JP6310631B2 (ja) * 2011-10-18 2018-04-11 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
ES2905716T3 (es) * 2016-09-29 2022-04-11 Meharry Medical College Péptidos derivados de la arginina deiminasa de S. cristatus como inhibidores bacterianos
CN111172177B (zh) * 2019-07-30 2023-08-08 镇江市江澜绿洲生物技术有限公司 cra4S1基因及其编码的蛋白和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5830710A (en) * 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US5523390A (en) 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
AU7822394A (en) * 1993-10-08 1995-05-04 Lion Corporation Fimbrillin protein of porphyromonas gingivalis
AUPN015794A0 (en) 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000507245A (ja) * 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓペプチドを含む免疫原性組成物および方法
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007529195A (ja) * 2003-08-15 2007-10-25 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インク． 歯周病の診断，治療，およびモニタリングのためのＰｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ毒性ポリヌクレオチドの同定
JP2010532766A (ja) * 2007-07-12 2010-10-14 オーラル ヘルス オーストラリア ピーティーワイ リミテッド バイオフィルムに対する免疫学的治療
JP2014058541A (ja) * 2007-07-12 2014-04-03 Oral Health Australia Pty Ltd バイオフィルムに対する免疫学的治療
JP2015178533A (ja) * 2009-08-02 2015-10-08 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ ポルフィロモナス・ジンジバリス（Ｐｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ）ポリペプチド
WO2012081306A1 (ja) * 2010-12-15 2012-06-21 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
JPWO2012081306A1 (ja) * 2010-12-15 2014-05-22 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
US8975032B2 (en) 2010-12-15 2015-03-10 Sunstar Inc. Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria
JP7891763B1 (ja) * 2025-03-11 2026-07-17 貴俊 村田 オリゴヌクレオチドセット及び口腔細菌検出用キット並びに口腔細菌の検出方法及び口腔病原細菌検出用オリゴヌクレオチドセットの製造方法

Also Published As

Publication number Publication date
EP2256204A1 (en) 2010-12-01
EP2264176A1 (en) 2010-12-22
EP2283852A3 (en) 2011-05-04
EP2256205B1 (en) 2013-04-03
ES2377751T3 (es) 2012-03-30
EP2283853A3 (en) 2011-05-11
EP2283853A2 (en) 2011-02-16
EP2283852A2 (en) 2011-02-16
KR100603552B1 (ko) 2006-07-20
EP1681350A3 (en) 2007-07-18
ATE534742T1 (de) 2011-12-15
AU1648799A (en) 1999-06-28
DK1908772T3 (da) 2012-03-19
KR20010033030A (ko) 2001-04-25
EP1681350A2 (en) 2006-07-19
EP2283854A3 (en) 2011-04-06
JP5349070B2 (ja) 2013-11-20
NZ504811A (en) 2003-10-31
EP1037999A4 (en) 2005-03-23
ES2419664T3 (es) 2013-08-21
EP2283855A2 (en) 2011-02-16
CA2313823A1 (en) 1999-06-17
WO1999029870A1 (en) 1999-06-17
EP1037999A1 (en) 2000-09-27
EP1908772A3 (en) 2008-12-03
EP1908772B1 (en) 2011-11-23
EP2256205A1 (en) 2010-12-01
EP2283855A3 (en) 2011-05-04
DK2256205T3 (da) 2013-07-08
JP2009136300A (ja) 2009-06-25
EP1908772A2 (en) 2008-04-09
EP2283854A2 (en) 2011-02-16

Similar Documents

Publication Publication Date Title
JP5349070B2 (ja) Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド
US8642731B2 (en) Porphyromonas gingivalis polypeptides and nucleotides
EZZELL et al. Serum protease cleavage of Bacillus anthracis protective antigen
JP2004135679A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓポリヌクレオチドおよび配列
US9180170B2 (en) Brucella abortus proteins and methods of use thereof
US6444799B1 (en) P. gingivalis polynucleotides and uses thereof
EP0946730B1 (en) Mutants of streptococcal toxin c and methods of use
US6669940B2 (en) Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
US7544777B2 (en) Porphorymonas gingivalis polypeptides and nucleotides
WO1998024911A2 (en) Mutants of streptococcal toxin a and methods of use
US20040047871A1 (en) Recombinant fusobacterium necrophorum leukotoxin vaccine and prepaation thereof
AU6128900A (en) Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
AU2010200996B2 (en) Porphyromonas gingivalis polypeptides and nucleotides
HK1110603A (en) Porphorymonas gingivalis polypeptides and polynucleotides
Barr et al. Ross et a1.
JP2012505209A (ja) Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅの新規毒力因子

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080714

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080812

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081106

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081113

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090317

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090615